Amy E. DeZern

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 41 papers. Top paper: “Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide”.

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020001729

N/A

5.5DataRank · unranked

149 citations

Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone +12 more

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Advances(2020)10.1182/bloodadvances.2020001648

N/A

3.1DataRank · unranked

74 citations

Marianna Zahurak, Yilin Cao, Allen Chen, Kenneth R. Cooke, Christopher Gamper +16 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Blood Advances(2023)10.1182/bloodadvances.2022009000

N/A

0.697DataRank · unranked

16 citations

Donnie Hebert, Cecilia Lee, Dana E. Rollison, Nancy Gillis, Rami S. Komrokji +15 more

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Blood Advances(2023)10.1182/bloodadvances.2023010061

N/A

0.554DataRank · unranked

12 citations

Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu +19 more

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Advances(2023)10.1182/bloodadvances.2022008578

N/A

0.543DataRank · unranked

9 citations

Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert +20 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome

Best Practice & Research Clinical Haematology(2021)10.1016/j.beha.2021.101280

N/A

0.470DataRank · unranked

22 citations

Amy E. DeZern, Theodoros Karantanos

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697

N/A

0.425DataRank · unranked

16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia

Journal of Oncology Pharmacy Practice(2021)10.1177/10781552211024727

N/A

0DataRank · unranked

12 citations

Bryan C. Hambley, Erin Hickey, Sarah Kashanian, Andrew Li, Maria R. Baer +11 more

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022

N/A

0DataRank · unranked

6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more

Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?

The Lancet Haematology(2022)10.1016/s2352-3026(22)00138-7

N/A

0DataRank · unranked

51 citations

Amy E. DeZern, Michael J. Hochman

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.02.004

N/A

0DataRank · unranked

27 citations

Hua‐Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños‐Meade +22 more

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.009

N/A

0DataRank · unranked

11 citations

Michael Sang Hughes, Hua‐Ling Tsai, Kathryn Yarkony, Ephraim J. Fuchs, Lode J. Swinnen +15 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes

Blood Advances(2023)10.1182/bloodadvances.2023010416

N/A

0DataRank · unranked

19 citations

Matthew Guo, Shiyu Wang, Kristin Stokvis, Audra Shedeck, Aparna Pallavajjala +8 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Considerations for Drug Development in Myelodysplastic Syndromes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3348

N/A

0DataRank · unranked

12 citations

Nina Kim, Amy E. DeZern, Kelly J. Norsworthy, Jacqueline S. Garcia, R. Angelo de Claro +6 more

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

Research Square(2023)10.21203/rs.3.rs-2802265/v1

N/A

0DataRank · unranked

2 citations

Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Riley E. Bergman +15 more

International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced

Cytotherapy(2024)10.1016/j.jcyt.2024.06.002

N/A

0DataRank · unranked

15 citations

Melissa Azul, Senthil Velan Bhoopalan, Allistair Abraham, Alice Bertaina, Alan Bidgoli +10 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Advancing drug development in myelodysplastic syndromes

Blood Advances(2024)10.1182/bloodadvances.2024014865

N/A

0DataRank · unranked

12 citations

Kathy L. McGraw, Lea Cunningham, Nina Kim, Emily Y. Jen, Katherine R. Calvo +17 more

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee

Cytotherapy(2024)10.1016/j.jcyt.2024.09.001

N/A

0DataRank · unranked

10 citations

Athena Russell, Amy E. DeZern, Susan E. Prockop, Carmem Bonfim, Akshay Sharma +8 more

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

Blood Advances(2024)10.1182/bloodadvances.2023011260

N/A

0DataRank · unranked

8 citations

Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou +19 more

Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.03.018

N/A

0DataRank · unranked

7 citations

Marianna Zahurak, Natalie S. Rosen, Amy E. DeZern, Richard J. Jones, Alexander J. Ambinder +1 more

Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

Cytotherapy(2024)10.1016/j.jcyt.2024.02.005

N/A

0DataRank · unranked

6 citations

Gayatri Shankar Chilambi, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Alan Bidgoli +15 more

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study

Blood Neoplasia(2024)10.1016/j.bneo.2024.100026

N/A

0DataRank · unranked

1 citations

Johannes B. Goll, Travis L. Jensen, Sridhar Nonavinkere Srivatsan, Nancy Gillis, Gregory A. Abel +14 more

A proposed path to explaining the unexplained anemia of aging

The Journals of Gerontology Series A(2025)10.1093/gerona/glaf251

N/A

0DataRank · unranked

2 citations

Amy E. DeZern, Janis L. Abkowitz, Andrew Artz, Isabel Beerman, Kelly L. Bolton +20 more

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

Leukemia Research(2025)10.1016/j.leukres.2025.108098

N/A

0DataRank · unranked

1 citations

Daniel Li, Hua‐Ling Tsai, Gabriel Ghiaur, B. Douglas Smith, Mark J. Levis +10 more

Unique epigenomic signatures identify biologically significant subtypes of MDS and predict response to azacitidine

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.23.650336

N/A

0DataRank · unranked

0 citations

Miguel Torres‐Martín, Masataka Taguchi, Alice Brogi, Irene Casalin, Eleonora Ceneri +12 more

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies

Current Hematologic Malignancy Reports(2025)10.1007/s11899-025-00762-1

N/A

0DataRank · unranked

0 citations

Amy E. DeZern, Shuyuan Mo

Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow Transplantation

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.11.009

N/A

0DataRank · unranked

0 citations

Marianna Zahurak, Ilias Sinanidis, Suraya A. Berger, Javier Bolaños‐Meade, Ephraim J. Fuchs +7 more

Cancer spectrum and outcomes in the Mendelian short telomere syndromes

Blood(2020)10.1182/blood.2019003264

N/A

0DataRank · unranked

133 citations

Lisa Haley, Sonye K. Danoff, Amanda L. Blackford, Amy E. DeZern, Christopher D. Gocke +3 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

Blood Advances(2020)10.1182/bloodadvances.2019001127

N/A

0DataRank · unranked

60 citations

Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson +8 more

Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.09.018

N/A

0DataRank · unranked

11 citations

Hua-Ling Tsai, Amy E. DeZern, Kevin Jerde, Lode J. Swinnen, Javier Bolaños‐Meade +13 more

Stem cell donors should be screened for CHIP

Blood Advances(2020)10.1182/bloodadvances.2019000394

N/A

0DataRank · unranked

41 citations

Lukasz P. Gondek, Amy E. DeZern

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

A 15‐year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism

American Journal of Hematology(2021)10.1002/ajh.26414

N/A

0DataRank · unranked

18 citations

Amy E. DeZern, Shruti Chaturvedi, Robert A. Brodsky, Gloria F. Gerber